These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25868965)

  • 1. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.
    Gill BS; Bernard ME; Lin JF; Balasubramani GK; Rajagopalan MS; Sukumvanich P; Krivak TC; Olawaiye AB; Kelley JL; Beriwal S
    Gynecol Oncol; 2015 Jun; 137(3):365-72. PubMed ID: 25868965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base.
    Chapman BV; Gill BS; Viswanathan AN; Balasubramani GK; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):107-117. PubMed ID: 27843030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study.
    Rydzewski NR; Kanis MJ; Donnelly ED; Lurain JR; Strauss JB
    Radiother Oncol; 2018 Dec; 129(3):534-539. PubMed ID: 29631932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
    Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adjuvant radiation therapy in older patients with node-positive vulvar cancer: A national cancer database analysis.
    Ni L; Sinha S; Rara M; Phuong C; Chen LM; Hsu IJ; Yoshida EJ
    Gynecol Oncol; 2022 Nov; 167(2):189-195. PubMed ID: 36150913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
    Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
    Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer.
    Ashmore S; Crafton SM; Miller EM; Krivak TC; Glaser SM; Teterichko SR; Sukumvanich P; Viswanathan AN; Beriwal S; Horne ZD
    Gynecol Oncol; 2021 Apr; 161(1):63-69. PubMed ID: 33500149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment.
    Woelber L; Eulenburg C; Choschzick M; Kruell A; Petersen C; Gieseking F; Jaenicke F; Mahner S
    Int J Gynecol Cancer; 2012 Mar; 22(3):503-8. PubMed ID: 22266935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.
    Xanthopoulos EP; Grover S; Puri PM; Corradetti MN; Heilbroner SP; Mitra N; Simone CB; Lin LL
    Am J Clin Oncol; 2018 Sep; 41(9):845-850. PubMed ID: 30134287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and Role of Adjuvant Radiotherapy and Chemotherapy for Uterine Clear Cell Carcinoma: A National Cancer Data Base Analysis.
    Xu KM; Gill BS; Balasubramani GK; Sukumvanich P; Kelley JL; Beriwal S
    Int J Gynecol Cancer; 2016 Mar; 26(3):472-82. PubMed ID: 26825837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.
    Gaulin NB; Lesnock JL; Tian C; Osei-Bonsu K; Jacobs A; Richard SD; Krivak TC; Miller EM; Shriver CD; Casablanca Y; Maxwell GL; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):136-145. PubMed ID: 31954540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary personalized approach in the management of vulvar cancer - the Vul.Can Team experience.
    Tagliaferri L; Garganese G; D'Aviero A; Lancellotta V; Fragomeni SM; Fionda B; Casà C; Gui B; Perotti G; Gentileschi S; Inzani F; Corrado G; Buwenge M; Morganti AG; Valentini V; Scambia G; Gambacorta MA; Macchia G
    Int J Gynecol Cancer; 2020 Jul; 30(7):932-938. PubMed ID: 32474446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.
    Swanick CW; Eifel PJ; Huo J; Meyer LA; Smith GL
    Gynecol Oncol; 2017 Jul; 146(1):87-93. PubMed ID: 28506563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
    Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
    Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.
    Ignatov T; Eggemann H; Burger E; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):489-95. PubMed ID: 26498775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.
    Winters BR; Kearns JT; Holt SK; Mossanen M; Lin DW; Wright JL
    Urol Oncol; 2018 Mar; 36(3):92.e11-92.e16. PubMed ID: 29174944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
    Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
    Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characterization of vulvar epithelioid sarcoma].
    Sun L; Wu LY; Li XG; Bai P; Zhang HT
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):935-8. PubMed ID: 21223804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
    Haque W; Verma V; Bernicker E; Butler EB; Teh BS
    Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.